Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.
about
Infiltrative CardiomyopathiesNuclear imaging modalities for cardiac amyloidosisEvolving landscape in the management of transthyretin amyloidosisCardiac sarcoidosis: case report, workup, and review of the literature.Guideline of transthyretin-related hereditary amyloidosis for clinicians.Senile systemic amyloidosis: clinical features at presentation and outcome.Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques.Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.Cardiovascular magnetic resonance for amyloidosis.Preclinical Validation of the Heparin-Reactive Peptide p5+14 as a Molecular Imaging Agent for Visceral AmyloidosisTransthyretin cardiac amyloidoses in older North Americans.Updates in cardiac amyloidosis: a review.Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis.Transthyretin (TTR) cardiac amyloidosis.Comparative evaluation of p5+14 with SAP and peptide p5 by dual-energy SPECT imaging of mice with AA amyloidosis.(99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosisCirculating matrix metalloproteinases and tissue inhibitors of metalloproteinases in cardiac amyloidosis.(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidosesGenotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).Cardiac amyloidosis: the heart of the matter.Molecular imaging of amyloidosis: will the heart be the next target after the brain?Nuclear imaging of amyloidosis.Nuclear imaging for cardiac amyloidosis.The transthyretin amyloidoses: advances in therapy.Novel strategies for the diagnosis and treatment of cardiac amyloidosis.A Plasma Cell Dyscrasia Presenting as Amyloid Cardiomyopathy and Autonomic Dysfunction in a Healthy Patient.Multimodality imaging in restrictive cardiomyopathies: an EACVI expert consensus document: In collaboration with the 'Working Group on myocardial and pericardial diseases' of the European Society of Cardiology Endorsed by the Indian Academy of EchocUse of Noninvasive Imaging in Cardiac Amyloidosis.Recent advances in the noninvasive strategies of cardiac amyloidosis.Wild-Type Transthyretin Cardiac Amyloidosis: Novel Insights From Advanced Imaging.New and Evolving Concepts Regarding the Prognosis and Treatment of Cardiac Amyloidosis.One mutation, two distinct disease variants: unravelling the impact of transthyretin amyloid fibril composition.Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans.Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis.Targeted Nuclear Imaging Probes for Cardiac Amyloidosis.Cardiac Amyloidosis: Diagnosis and Treatment Strategies.Imaging of Left Ventricular Hypertrophy: a Practical Utility for Differential Diagnosis and Assessment of Disease Severity.Tc-99m Radiolabeled Peptide p5 + 14 is an Effective Probe for SPECT Imaging of Systemic Amyloidosis.Cardiac Amyloidosis and its New Clinical Phenotype: Heart Failure with Preserved Ejection Fraction.Echocardiographic and biohumoral characteristics in patients with AL and TTR amyloidosis at diagnosis.
P2860
Q26798533-32235CBB-918B-4543-82D7-3AE314576522Q27024756-EB938B3D-AF7A-4B5D-83D1-B4E6242C38EEQ28086773-E15CC7EA-5194-43B9-820F-9AA75A969BF1Q30434303-C9DDE0C4-73F9-4BFC-8FAB-ABF40C3CDB3FQ34328734-37F3EFE3-2216-4CE0-A50F-A6DE424BABFCQ34340740-ACB0DB1D-2B7C-4EB8-B4F1-A0C81BBCBD3EQ34392552-BF27C5E3-CECD-4561-9FA3-256048361156Q34487487-87E5F52A-5A8D-463D-942E-FB10436158F7Q35535955-1D0F9339-56D9-488D-B0C1-C1F1B289182EQ35639988-DD8AE745-A0E5-452F-B7B4-24A27D229F05Q35886169-7543F88F-66E2-473D-8913-58FC20C257CAQ36366356-7BF48350-DC26-4F17-8D20-E526D91BE893Q36384508-D513D190-36AE-40D5-B857-04DCB59F86C9Q36408438-8A012087-FD24-4221-8C91-18875CF08E6BQ36645348-09C0F527-14C0-4640-8288-E64949D7D659Q36740688-E270CB98-D6F0-4D61-B3A9-E8D1325FED70Q36824706-368F5F8B-A8D1-40FC-ABF9-9AFD621EB9CBQ37054790-FA0773B1-474F-4C4E-AC41-B6C6955C2DFDQ37083158-8E02813B-179C-488B-98E6-D4C44E028EE7Q37899075-1DDD1ED3-B25A-43CF-8D26-25DC4212CB14Q37970935-F388DAC3-920D-4B76-ADD2-74A3E65CB9E7Q38234973-45B3E15E-77B6-431E-9755-E967BECE7095Q38271439-EA379702-6429-4C3F-80D8-B3A53194E936Q38517905-9890FAC3-12B1-443B-8482-79EF106CDD2BQ38614967-8402C697-FC73-46BB-B206-70136BB48126Q38634630-27BAB0ED-DF87-49B4-8D39-7A12DDA8A4BCQ38782767-85E138B5-1556-4EBC-943B-E86CFC9BC4C3Q38834998-0F6C277F-61BE-4921-AEFB-8F2EBDDEA7D2Q38935425-62E974EC-001A-4799-971B-0A98BE184190Q38939270-E8C8813D-658E-404A-AE86-F0BBDE4723E2Q39024208-A4A5FC03-1B5B-4157-A26C-5A17D0A626C2Q39091511-BBA69807-984D-4ACF-80FF-0C81AC1E1691Q39095033-682B4AB4-72EE-4F3A-A3B7-B3092E8B889DQ39217713-BC53B946-E61F-4408-BD66-412E97B80C8FQ39309126-B0F188FA-FDD9-4A84-B79F-5ACDCBC60EB4Q39320411-D6FA854B-CB86-4BDA-B3D7-39C83E782E33Q39390119-835D5D01-A0B5-43B5-A4CB-FD68333ED35FQ40316884-E12D35C5-C4BA-4018-BF5E-541F336AB2BBQ41106725-669478A0-F31A-4F21-8F11-7622F13523E6Q41489706-FF2E76B3-47C4-43D1-AF0A-021D1829D879
P2860
Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Noninvasive etiologic diagnosi ...... icarboxylic acid scintigraphy.
@en
type
label
Noninvasive etiologic diagnosi ...... icarboxylic acid scintigraphy.
@en
prefLabel
Noninvasive etiologic diagnosi ...... icarboxylic acid scintigraphy.
@en
P2093
P50
P1476
Noninvasive etiologic diagnosi ...... icarboxylic acid scintigraphy.
@en
P2093
Angelo Branzi
Enrica Perugini
Fabrizio Salvi
Francesco Fallani
Letizia Bacchi-Reggiani
Letizia Riva
Mohsen Farsad
Paolo Ciliberti
Pier Luigi Guidalotti
Robin M T Cooke
P304
P356
10.1016/J.JACC.2005.05.073
P407
P577
2005-09-01T00:00:00Z